Fact checked by Jennifer Klump Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is ...

A doctor recently determined that columnist Brianna Albers had an airway collapse, but she'd been dwelling on something much worse.

RNS60 was well tolerated when inhaled twice daily at home as part of an expanded access program (EAP) for people with ...

Multi-media patient education support materials and built-in conveniences make this efficient nebulizer system the ideal choice for encouraging adherence to aerosol medication treatment plans.